ADmit Therapeutics
Developer of a medical diagnostic test designed for the early detection of Alzheimer's disease. The company's diagnostic test is based on an epigenetic analysis in blood samples that covers methylcyto...
Valuation
$0
Share Price
N/A
Total Raised
$37.5M
Last Round
N/A